ILMN

Ride This Biotech’s Powerful Bull Trend

Illumina jumped to a 20-month high and is under heavy accumulation. More 

Top 6 Stocks to Buy for May

As we enter a period of historical seasonal weakness, this month's list contains stocks that are in powerful bull markets. More 

Life Science Stocks Aren’t Completely Hopeless, But …

A government sequestration won't rip into all life sciences stocks equally, but its presence will be felt -- a grim possibility for an already-struggling industry. More 

Hedge Fund Darlings That Look Like ‘Sells’

Of the top 50 stocks held by hedge funds, these 14 are rated a “strong sell” by my technical parameters. More 

Euro, Mexico, Oh No! — Monday’s IP Market Recap

Bribery accusations hampering Wal-Mart and worries in Europe in China weighed on markets in Monday trading. More 

Cue the Biotech M&A Attack!

A rush of buyout activity in biotechs like Human Genome and Illumina could produce more frenzied M&A deals down the road. More 

Nasdaq’s Big Names Romp — Thursday’s IP Market Recap

Google (GOOG) surged before Thursday's earnings report, then announced an 'effective' stock split. Meanwhile, Starbucks hit an all-time high. More